Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/1992
09/16/1992EP0503180A2 Improved antiperspirant formulations
09/16/1992CN1064407A Pharmaceutical composition
09/15/1992CA2062854A1 Pharmaceutical aerosol formulations
09/15/1992CA1307463C Sustained release pharmaceutical compositions
09/09/1992EP0502616A1 Cosmetic composition
09/09/1992EP0214281B1 Protein absorption enhancing agents
09/08/1992US5145611 Diabetes
09/03/1992WO1992014743A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
09/03/1992WO1992014477A1 Method of treating systemic lupus erythematosus
09/03/1992WO1992014476A1 Method of treating pulmonary inflammation
09/03/1992CA2103568A1 Method of treating systemic lupus erythematosus
09/02/1992EP0501293A1 Use of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition
09/02/1992EP0500658A1 A nicotine containing stimulant unit.
09/02/1992EP0495918A4 Amino acid beta-lyase enzyme inhibitors as deodorants
09/01/1992US5143718 Aluminum Chloride, Aluminum Salt of Organic Acid
09/01/1992CA1306952C Coupler of 2,4-diamino-1,3-dimethoxybenzene, or one of its salts, associated with oxidation dye precursors, used to dye human hair, composition of hair dyecontaining such coupler and process for the preparation of said coupler
08/1992
08/26/1992CN1063818A Improved antiperspirant formulations
08/26/1992CA2061536A1 Use of s-adenosyl-l-menthionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition
08/25/1992US5141905 Bone morphogenic proteins induce bone and/or cartilage formation
08/25/1992CA1306694C Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus
08/20/1992WO1992013826A1 Compositions and method for soft tissue tumors
08/20/1992WO1992013571A1 Method of treating and/or diagnosing soft tissue tumors
08/20/1992WO1992013520A1 Composition
08/20/1992WO1992013516A2 Improved antiperspirant formulations
08/20/1992CA2101638A1 Composition
08/19/1992EP0499489A1 Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
08/19/1992EP0499467A2 Use of quinones in the treatment of cancer or AIDS
08/19/1992EP0499304A1 Clear cosmetic sticks with compatible fragrance compositions
08/19/1992EP0499098A2 Method of treating and/or diagnosing soft tissue tumors
08/19/1992CN1017893B Process for the preparation of heterocyclic derivatives
08/17/1992CA2104108A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists
08/15/1992CA2060915A1 Cleaning composition
08/14/1992WO1992014454A1 Use of quinones in the treatment of cancer or aids
08/14/1992CA2104009A1 Use of quinones in the treatment of cancer or aids
08/12/1992EP0498636A1 Cosmetic composition
08/12/1992EP0497952A1 Composition for the topical treatment of psoriasis
08/12/1992EP0497926A1 Multi-site metal chelating agents
08/12/1992EP0497910A1 Camptothecin analogs as potent inhibitors of human colorectal cancer
08/12/1992EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility
08/12/1992EP0225329B1 Non-adjuvenated vaccine
08/12/1992CN1063415A Methods for preparing alleviating menopausal symptoms
08/11/1992US5137714 Anhydrous cosmetic composition comprising stable lower alkyl esters of pyroglutamic acid
08/11/1992CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
08/11/1992CA1306198C Cosmetic product
08/10/1992CA2060937A1 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
08/08/1992CA2038789A1 Antiperspirant formulations
08/05/1992EP0497476A2 Antiplaque oral compositions
08/05/1992EP0497356A1 Compositions and method for soft tissue tumors
08/05/1992EP0497192A2 Amino acid derivatives
08/04/1992US5135921 Pharmaceutical compositions comprising phosphatidyl carnitine for the treatment of human pathologies associated with neuronal damage
08/04/1992US5135747 Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant
08/02/1992CA2058797A1 Amino acid derivatives
07/1992
07/31/1992CA2060332A1 Method of treating and/or diagnosing soft tissue tumors
07/30/1992DE4101910A1 Verfahren zur herstellung eines pyrogenfreien gut wasserloeslichen fructans sowie ein nierendiagnostikum, das ein solches fructan enthaelt Process for the preparation of a pyrogen well wasserloeslichen fructans and a renal diagnostic that such a fructan contains
07/29/1992EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole
07/29/1992EP0496308A1 Intranasal compositions comprising 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methynesulphonamide
07/29/1992EP0495918A1 Amino acid beta-lyase enzyme inhibitors as deodorants.
07/28/1992CA1305671C Photostable cosmetic preparation containing a uv-a filter and a uv-b filter, its use to protect the skin against uv rays and technique of stabilization of the uv-a filter by the uv-b filter
07/25/1992WO1992012712A1 Compositions
07/25/1992CA2100569A1 Compositions
07/24/1992WO1992013005A1 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function
07/23/1992WO1992012123A1 Anti-viral compounds
07/23/1992WO1992011855A1 Compositions and methods for alleviating menopausal symptoms
07/22/1992EP0597830A4 Use of polyamines as ionic-channel regulating agents.
07/22/1992EP0495321A1 Rapid miosis with control of intraocular pressure
07/22/1992EP0175709B1 Substance, composition of matter and method of using same
07/15/1992EP0223831B1 Liposome inhalation method and system
07/15/1992CN1062730A N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
07/15/1992CN1062654A Gel type compositions having improved oil control
07/15/1992CN1017451B Method for the preparation of vaccine
07/14/1992US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals
07/14/1992CA1305183C 2,4-diamino-1,3,5-trimethoxybenzene, a process for its preparation and itsuse as a coupler in oxidation dyes for keretinic fibers
07/14/1992CA1305067C Cosmetic product
07/14/1992CA1305053C Synthetic polymeric drugs
07/08/1992EP0493861A2 Antidepressive composition containing nicotinamid-adenin-dinucleotide
07/08/1992EP0202282B1 New use of 1,4-dihydropyridine derivatives
07/08/1992CN1062537A Heparin derivatives
07/07/1992US5128121 Mixture of a positive and negative contrast agent for magnetic resonance imaging
07/07/1992CA1304740C Quaternary ammonium retinoates, their use as cosmetics and as dermotherapic medecine
07/01/1992EP0492485A1 N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
07/01/1992EP0423318A4 Therapeutic cholesterol gallstone dissolution method
07/01/1992EP0308436B1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment
06/1992
06/30/1992US5126135 Dermatological composition based on an aqueous phase
06/24/1992CN1062138A Synergism of hiv reverse transcriptase inhibitors
06/23/1992CA1303999C Filtrating cosmetic composition in the form of an oil-in-water emulsion comprising a uv-a and a uv-b filter and its use for protecting the skin against ultra-violet rays
06/23/1992CA1303998C Transparent cosmetic composition reflecting infrared rays and its use for theprotection of human skin against infrared rays
06/21/1992WO1992011294A1 Heparin derivatives
06/21/1992WO1992011019A1 Psyllium and cholestyramine compositions with improved palatability
06/21/1992CA2075970A1 Heparin derivatives
06/20/1992WO1992011018A1 Improved humanized immunoglobulins
06/17/1992EP0490041A1 Cosmetic composition
06/17/1992EP0489775A1 Hair-dyeing process using direct dyes
06/17/1992EP0185680B1 Steroidal liposomes
06/16/1992CA1303505C Anti-tumor compositions containing 5, 5-dimethyl-2- phenyl-4-thiazolidine carboxylic acid or 5, 5- dimethyl-2-(2-hydroxyphenyl)-4-thiazolidine carboxylic acid
06/11/1992WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions
06/11/1992WO1992009273A1 Retarded-action urapidil formulation
06/11/1992WO1992009266A1 Topical composition
06/11/1992CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions
06/10/1992EP0489144A1 Freeze-dried hybrid mild pumpkin and drugs containing same
06/10/1992CN1061720A Vitamin-mineral compositions and treatment method